32
Participants
Start Date
July 6, 2022
Primary Completion Date
March 1, 2026
Study Completion Date
March 1, 2027
Fludarabine
Fludarabine phosphate is a synthetic purine nucleoside analog. It acts by inhibiting DNA polymerase, ribonucleotide reductase and DNA primase by competing with the physiologic substrate, deoxyadenosine triphosphate, resulting in inhibition of DNA synthesis. Intravenous
Cyclophosphamide
Cyclophosphamide is a nitrogen mustard derivative. It acts as an alkylating agent that causes cross-linking of DNA strands by binding with nucleic acids and other intracellular structures, thus interfering with the normal function of DNA. Intravenous
MESNA
Mesna is a synthetic sulfhydryl (thiol) compound. Mesna contains free sulfhydryl groups that interact chemically with urotoxic metabolites of oxaza-phosphorine derivatives such as cyclophosphamide and ifosfamide
B7-H3 CAR T cells
The study participant will receive B7-H3-CAR T cells by vein, through either an IV or a central line.
RECRUITING
St. Jude Children's Research Hospital, Memphis
St. Jude Children's Research Hospital
OTHER